PL361667A1 - Kompozycje N-(metyloetyloaminokarbonylo)-4-(3-metylofenyloamino)-3-pirydylosulfonamidu i cyklicznych oligosacharydów - Google Patents

Kompozycje N-(metyloetyloaminokarbonylo)-4-(3-metylofenyloamino)-3-pirydylosulfonamidu i cyklicznych oligosacharydów

Info

Publication number
PL361667A1
PL361667A1 PL01361667A PL36166701A PL361667A1 PL 361667 A1 PL361667 A1 PL 361667A1 PL 01361667 A PL01361667 A PL 01361667A PL 36166701 A PL36166701 A PL 36166701A PL 361667 A1 PL361667 A1 PL 361667A1
Authority
PL
Poland
Prior art keywords
pyridylsulfonamide
methylethylaminocarbonyl
methylphenylamino
compositions
cyclic oligosaccharides
Prior art date
Application number
PL01361667A
Other languages
English (en)
Inventor
Miljenko Dumic
Darko Filic
Bozena Klepic
Aleksandar Danilovski
Marijan Tudja
Original Assignee
Pliva, Farmaceutska Industrja, Dionicko Drustvo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva, Farmaceutska Industrja, Dionicko Drustvo filed Critical Pliva, Farmaceutska Industrja, Dionicko Drustvo
Publication of PL361667A1 publication Critical patent/PL361667A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PL01361667A 2000-11-10 2001-01-31 Kompozycje N-(metyloetyloaminokarbonylo)-4-(3-metylofenyloamino)-3-pirydylosulfonamidu i cyklicznych oligosacharydów PL361667A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HR20000765A HRP20000765A2 (en) 2000-11-10 2000-11-10 Compositions of n-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides with increased release
PCT/HR2001/000004 WO2002038186A1 (en) 2000-11-10 2001-01-31 Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides

Publications (1)

Publication Number Publication Date
PL361667A1 true PL361667A1 (pl) 2004-10-04

Family

ID=10947206

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01361667A PL361667A1 (pl) 2000-11-10 2001-01-31 Kompozycje N-(metyloetyloaminokarbonylo)-4-(3-metylofenyloamino)-3-pirydylosulfonamidu i cyklicznych oligosacharydów

Country Status (26)

Country Link
US (1) US7037928B2 (pl)
EP (1) EP1347780B1 (pl)
JP (1) JP2004513155A (pl)
KR (1) KR20030060929A (pl)
CN (1) CN1477977A (pl)
AR (1) AR026815A1 (pl)
AU (1) AU2001228721A1 (pl)
BG (1) BG107896A (pl)
BR (1) BR0115281A (pl)
CA (1) CA2428179A1 (pl)
CZ (1) CZ20031490A3 (pl)
DE (1) DE60125828T2 (pl)
EA (1) EA005111B1 (pl)
EE (1) EE200300197A (pl)
GE (1) GEP20043403B (pl)
HR (1) HRP20000765A2 (pl)
HU (1) HUP0400776A2 (pl)
IL (1) IL155818A0 (pl)
IS (1) IS6810A (pl)
MX (1) MXPA03004111A (pl)
NO (1) NO20032091L (pl)
PL (1) PL361667A1 (pl)
SK (1) SK6722003A3 (pl)
WO (1) WO2002038186A1 (pl)
YU (1) YU35303A (pl)
ZA (1) ZA200303601B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
GEP20094781B (en) * 2004-01-22 2009-09-25 Pfizer Sulfonamide derivatives for the treatment of diseases
CN100372534C (zh) * 2006-04-20 2008-03-05 南京海辰药业有限公司 托拉塞米冻干制剂及制备方法
CN101743001B (zh) 2007-04-13 2013-02-06 千年药品公司 用起因子xa抑制剂作用的化合物的组合抗凝治疗
BR102012009317B1 (pt) * 2012-04-20 2022-05-31 Universidade Federal De Minas Gerais - Ufmg Processo de preparação de compostos de inclusão envolvendo ciclodextrinas e fármacos, usando um sistema de fluxo contínuo
ES2858551T3 (es) * 2015-06-16 2021-09-30 Atxa Therapeutics Ltd Antagonistas del receptor de tromboxano
US12403120B2 (en) 2018-12-10 2025-09-02 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof
EP3906019B1 (en) 2019-01-04 2025-11-26 SQ Innovation AG Pharmaceutical compositions of furosemide
EP3906020B1 (en) 2019-01-04 2025-12-31 SQ Innovation AG Pharmaceutical compositions of torsemide and their uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US576511A (en) * 1897-02-02 Georg steinike and friedrich schmidt
DE3529529A1 (de) * 1985-08-17 1987-02-19 Boehringer Mannheim Gmbh Verfahren zur herstellung einer stabilen modifikation von torasemid
EP0807361B1 (en) * 1995-12-01 2005-11-23 Koninklijke Philips Electronics N.V. A digital cordless telephony system, a radio base station, and a combination of a radio base station and a cordless handset
US6828334B2 (en) * 2002-05-23 2004-12-07 Usv Limited Fenofibrate-cyclodextrin inclusion complexes and their pharmaceutical composition

Also Published As

Publication number Publication date
EA200300556A1 (ru) 2003-08-28
GEP20043403B (en) 2004-06-10
YU35303A (sh) 2006-03-03
HUP0400776A2 (hu) 2004-08-30
DE60125828T2 (de) 2007-08-16
DE60125828D1 (de) 2007-02-15
MXPA03004111A (es) 2004-05-05
KR20030060929A (ko) 2003-07-16
CZ20031490A3 (cs) 2003-08-13
AR026815A1 (es) 2003-02-26
IL155818A0 (en) 2003-12-23
EA005111B1 (ru) 2004-10-28
AU2001228721A1 (en) 2002-05-21
BG107896A (bg) 2004-01-30
WO2002038186A1 (en) 2002-05-16
HRP20000765A2 (en) 2002-06-30
EP1347780A1 (en) 2003-10-01
EE200300197A (et) 2003-08-15
JP2004513155A (ja) 2004-04-30
EP1347780B1 (en) 2007-01-03
BR0115281A (pt) 2003-07-29
NO20032091L (no) 2003-07-02
CA2428179A1 (en) 2002-05-16
CN1477977A (zh) 2004-02-25
ZA200303601B (en) 2004-07-19
US7037928B2 (en) 2006-05-02
NO20032091D0 (no) 2003-05-09
IS6810A (is) 2003-05-08
SK6722003A3 (en) 2003-10-07
US20040039204A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
HUP0300203A3 (en) Novel cyclic amide derivatives, and pharmaceutical compositions containing same
AU8670901A (en) Fabric care compositions comprising cationic silicones and methods employing same
HUP0400048A3 (en) N-aroyl cyclic amines and pharmaceutical compositions containing them
HUP0303621A3 (en) Pharmaceutical compositions containing combinations comprising an antidiarrheal agent and epothilone or an epothilone
EP1250142A4 (en) ADDED COMPOSITIONS WITH ELECTRONIC ELECTRODES AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU6118001A (en) Combination therapeutic compositions and methods of use
IL141767A0 (en) Use of heteroaryl substituted n- (indole-2-carbonyl-) amides for treatment of infection
GB0122854D0 (en) Dynamic damper and dynamic damper-installed racket
HUP0301713A3 (en) Pharmaceutical compositions containing propenone derivatives and their use
HUP0402318A3 (en) Pharmaceutical composition comprising cyclosporin and use thereof
IL155818A0 (en) Compositions of n-(methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridyl-sulfonamide and cyclic oligosaccharides
AU1365102A (en) Pour-on application method and devices
AU2001257457A1 (en) Vibration dampening compositions and methods thereof
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
SG100745A1 (en) Ceramic composition and ceramic capacitor
DE60105565D1 (de) Stabiles und wirksames weiches feststoffprodukt
DE60024476D1 (de) Pedikulizide und veterinärmedizinische zusammensetzungen
PL365602A1 (pl) Kompozycje farmaceutyczne i sposoby ich stosowania
AU3022201A (en) Novel use of (R)-(-)-2-(5-(4-fluorophenyl)-3-pyridylmethylaminomethyl)- chromane and its physiologically aceptable salts
IL153897A0 (en) Pharmaceutical compositions and methods for use
HUP0204560A3 (en) Heterocyclic amide derivatives and pharmaceutical compositions containing them and their use
AU8975701A (en) Novel composition and use
ATE350065T1 (de) Zusammensetzungen aus n- (methylethylaminocarbonyl)-4-(3- methylphenylamino)-3-pyridylsulfonamid und zyklischen oligonukleotiden
EP1414427A4 (en) KAVALACTONE COMPOSITIONS AND METHODS OF USE
AU2001276716A1 (en) Cyclic amine derivatives and use thereof

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)